Carole D. Gleeson

Real-World Outcomes and Costs Following 6 Months of Treatment with the Long-Acting Injectable (LAI) Aripiprazole Lauroxil for the Treatment of Schizophrenia

J. Lauriello, P. Weiden, L. Boulanger, 2021, CNS Drugs.

Risk factors and costs associated with 30-day readmissions following alcohol-related hospitalizations in the US from 2010-2015.

D. Hasin, J. Sussell, D. Goldman, 2020, Alcohol.